SYNTHESE VON NOROXYMORPHON
European patent · EP3720862 · In force
Register entry
- Publication number
- EP3720862
- Application number
- EP18814822
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 29, 2018
- Published
- Oct 14, 2020
- Granted
- Oct 27, 2021
- Protection ends at the latest
- Nov 28, 2038
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07D 498/08 (2006.01)A61P 25/04 (2006.01)A61K 31/485 (2006.01)
- Priority
- EP 17205507 05.12.2017
- PCT application
- PCT/EP2018/082986 29.11.2018
- PCT publication
- WO2019/110413 13.06.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Jan 31, 2023
Change
Published in Swissreg on 31.01.2023
- Sep 7, 2022
Change
Published in Swissreg on 07.09.2022
- Nov 25, 2021
Agent entered
- Representative
- TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly
Published in Swissreg on 25.11.2021
- Oct 27, 2021
Granted
Published in Swissreg on 27.10.2021
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.